Related Experiment Video
Updated: Jun 17, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Nuclear inositide signaling in myelodysplastic syndromes
Matilde Y Follo1, Sara Mongiorgi, Carlo Finelli
1Cellular Signaling Laboratory, Department of Human Anatomical Sciences, University of Bologna, via Irnerio 48, 40126 Bologna, Italy.
Abstract:
Myelodysplastic syndromes (MDS) are defined as clonal hematopoietic stem-cell disorders characterized by ineffective hematopoiesis in one or more of the lineages of the bone marrow. Although distinct morphologic subgroups exist, the natural history of MDS is progression to acute myeloid leukemia (AML). However, the molecular the mechanisms the underlying MDS evolution to AML are not completely understood. Inositides are key cellular second messengers with well-established roles in signal transduction pathways, and nuclear metabolism elicited by phosphoinositide-specific phospholipase C (PI-PLC) beta1 and Akt plays an important role in the control of the balance between cell cycle progression and apoptosis in both normal and pathologic conditions. Recent findings evidenced the role played by nuclear lipid signaling pathways, which could become promising therapeutic targets in MDS. This review will provide a concise and updated revision of the state of art on this topic.
Insights
Myelodysplastic syndromes (MDS) involve ineffective blood cell production and can progress to acute myeloid leukemia (AML). Nuclear lipid signaling pathways are emerging as potential therapeutic targets for MDS.
Area of Science:
- Hematology
- Molecular Biology
- Cell Biology
Background:
- Myelodysplastic syndromes (MDS) are clonal hematopoietic stem-cell disorders.
- MDS is characterized by ineffective hematopoiesis and can progress to acute myeloid leukemia (AML).
- The molecular mechanisms driving MDS progression to AML remain incompletely understood.
Purpose of the Study:
- To review the current understanding of molecular mechanisms in MDS.
- To highlight the role of nuclear lipid signaling in MDS.
- To discuss potential therapeutic targets in MDS.
Main Methods:
- Literature review of recent findings on inositides and MDS.
- Analysis of the role of phosphoinositide-specific phospholipase C (PI-PLC) beta1 and Akt in cellular processes.
- Discussion of nuclear lipid signaling pathways.
Main Results:
- Inositides act as crucial second messengers in signal transduction.
- Nuclear metabolism involving PI-PLC beta1 and Akt influences cell cycle and apoptosis.
- Nuclear lipid signaling pathways show promise as therapeutic targets for MDS.
Conclusions:
- Nuclear lipid signaling pathways are implicated in the pathogenesis of MDS.
- Targeting these pathways may offer novel therapeutic strategies for MDS.
- Further research into nuclear lipid metabolism is warranted for MDS treatment.
More Related Videos
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Intracellular Signaling Affects Focal Adhesions
Some...
Nuclear Localization Signals and Import
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Regulation of Nuclear Protein Sorting

